Cwm LLC Sells 2,041 Shares of Avantor, Inc. (NYSE:AVTR)

Cwm LLC reduced its stake in Avantor, Inc. (NYSE:AVTR) by 34.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,940 shares of the company’s stock after selling 2,041 shares during the period. Cwm LLC’s holdings in Avantor were worth $90,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in AVTR. Fifth Third Bancorp boosted its position in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after buying an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Avantor by 565.5% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after acquiring an additional 1,131 shares during the last quarter. CKW Financial Group acquired a new stake in shares of Avantor during the 4th quarter valued at $55,000. ORG Partners LLC bought a new stake in Avantor during the 4th quarter worth $89,000. Finally, Signaturefd LLC increased its holdings in Avantor by 41.7% in the 3rd quarter. Signaturefd LLC now owns 5,979 shares of the company’s stock worth $126,000 after purchasing an additional 1,759 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP James Bramwell sold 6,203 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares in the company, valued at $2,476,992.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Avantor Stock Down 0.1 %

Shares of Avantor stock opened at $24.85 on Wednesday. The stock’s 50-day moving average is $25.11 and its 200 day moving average is $22.80. Avantor, Inc. has a one year low of $16.63 and a one year high of $26.16. The firm has a market cap of $16.88 billion, a price-to-earnings ratio of 63.71, a PEG ratio of 1.50 and a beta of 1.36. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The company’s revenue was down 5.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.29 earnings per share. Equities research analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on AVTR shares. UBS Group lifted their price target on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Evercore ISI lifted their target price on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Citigroup upped their price target on shares of Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, April 18th. Finally, Raymond James boosted their price objective on shares of Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research note on Friday, January 26th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.71.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.